<DOC>
	<DOCNO>NCT00464763</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety dexmedetomidine prevention postoperative delirium subject undergoing heart valve surgery without coronary artery bypass surgery ( CABG ) use cardiopulmonary bypass ( CPB ) .</brief_summary>
	<brief_title>A Research Study Evaluate Effectiveness Dexmedetomidine Preventing Delirium After Heart Surgery</brief_title>
	<detailed_description>Postoperative delirium acute decline cognition attention usually transient delirium persists , impact cognitive function , morbidity mortality . Currently , drug prevent delirium dexmedetomidine potential meet unmet medical need . Dexmedetomidine currently approve use 24 hour patient ventilator Intensive Care Unit ( ICU ) . This study determine whether dexmedetomidine prevent delirium heart surgery . Study participation last randomization prior surgery , 3 day surgery . Dexmedetomidine give intravenous catheter begin sternal closure continue throughout stay ICU . Delirium assess prior surgery 72 hour surgery . This assessment consist question evaluate memory thought process . Thirty day surgery , question ask regard patient feeling health status hospital billing information collect .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Adult ( ≥18 year old ) male female undergo elective heart valve surgery ( without CABG use CPB ) general anesthesia require overnight stay ICU follow surgery . If female , subject nonlactating either : 1 . Not childbearing potential , defined postmenopausal least 1 year surgically sterile due bilateral tubal ligation , bilateral oophorectomy hysterectomy . 2 . Of childbearing potential pregnant time baseline practice one follow method birth control : oral parenteral contraceptive , doublebarrier method , vasectomized partner , abstinence sexual intercourse . Subject American Society Anesthesiologists ( ASA ) Physical Status II , III , IV . Subject ( subject 's legally authorize representative ) voluntarily sign date informed consent document approve Institutional Review Board ( IRB ) . Cognitive function level Mini Mental State Exam ( MMSE ) ≤ 20 screening . Subject positive CAMICU result delirium Screening . Subject require chronic antipsychotic therapy . Subject participate trial experimental drug experimental implantable device within 30 day prior study drug administration , ever enrol study . Subject know liver failure . Subject anticipated potential increase intracranial pressure uncontrolled seizure disorder know psychiatric illness could confound normal response study assessment . Subject acute myocardial infarction , HR &lt; 50 bpm , SBP &lt; 90 mmHg , hemodynamically unstable require systemic inotropic drug intraaortic counterpulsation balloon pump within last 72 hour . Subject anticipated require hypothermic circulatory arrest surgical procedure . Subject receive treatment α2agonist antagonist ( within 14 day study entry ) . Subject opiate , propofol , Dexmedetomidine α2agonists contraindicate . Subject , per investigator 's judgment , know suspected physical psychological dependence abuse drug , alcohol . Subject condition factor , Investigator 's opinion , might increase risk subject . Subject expect live 60 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Mental Health</keyword>
	<keyword>Neurological Disease</keyword>
	<keyword>Heart Valve Repair Surgery</keyword>
</DOC>